Ellis Investment Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-465
Closed -$11K 685
2022
Q3
$11K Buy
465
+60
+15% +$2.1K ﹤0.01% 563
2022
Q2
$13K Buy
405
+128
+46% +$5.44K ﹤0.01% 548
2022
Q1
$19K Buy
277
+122
+79% +$8.79K ﹤0.01% 539
2021
Q4
$14K Buy
155
+29
+23% +$3.47K ﹤0.01% 586
2021
Q3
$15K Buy
126
+3
+2% +$437 ﹤0.01% 554
2021
Q2
$20K Buy
123
+45
+58% +$7.29K 0.01% 515
2021
Q1
$14K Buy
78
+7
+10% +$1.62K ﹤0.01% 538
2020
Q4
$14K Buy
71
+66
+1,320% +$13.4K ﹤0.01% 525
2020
Q3
$1K Buy
+5
New +$1.06K ﹤0.01% 704

Other funds holding TDOC

Ellis Investment Partners's TDOC Position: Q4 2022 in Review

Ellis Investment Partners sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 465 shares — an estimated $11K sold.

Ellis Investment Partners first reported a position in TDOC in Q3 2020 and held it in 9 quarters. The position peaked at $20K in Q2 2021. 444 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Ellis Investment Partners reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 465 Teladoc Health shares in Q4 2022, an estimated $11K.
  • Ellis Investment Partners first reported a position in Teladoc Health in Q3 2020 and held it in 9 quarters.
  • Ellis Investment Partners's Teladoc Health position peaked at $20K in Q2 2021.
  • 444 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.